Cholestasis
Cholestasis is a medical condition that involves the disruption of the normal flow of bile from the liver to the small intestine. Bile is a digestive fluid produced by the liver that helps in the digestion and absorption of fats and fat-soluble vitamins. Cholestasis can occur when there is a problem with the bile ducts, liver cells, or the processes involved in bile production and transport.
There are two main types of cholestasis:
1.Intrahepatic Cholestasis
2.Extrahepatic Cholestasis
Related Conference of Cholestasis
September 29-30, 2025
7th International Conference on Gastroenterology and Liver Diseases
Paris, France
October 20-21, 2025
24th International Conference on Gastroenterology and Digestive Disorders
Osaka, Japan
January 19-20, 2026
26th International Conference on Gastroenterology and Hepatology
Vienna, Austria
April 20-21, 2026
20th World Congress on Gastroenterology -Therapeutics & Hepatology
Barcelona, Spain
May 21-22, 2026
17th International Conference on Liver Diseases & Hepatology
Aix-en-Provence, France
Cholestasis Conference Speakers
Recommended Sessions
- Acute pancreatitis
- Cholestasis
- Gallstones
- Hemochromatosis
- Hepatitis
- Hepatocellular Carcinoma
- Hepatology
- Jaundice
- Liver Cancer
- Liver cirrhosis
- Liver diseases
- Liver Fibrosis
- Liver Transplantation
- Non-Alcoholic Fatty Liver Disease (NAFLD)
- Pancreatic cancer
- Pediatric hepatology
- Regenerative Medicine and Liver Regeneration
- Wilson disease
Related Journals
Are you interested in
- Abdominal Health & Frontline Medicine - Gastrosummit 2025 (France)
- Advances in Gastrointestinal Cancer Management - Gastrosummit 2025 (France)
- Advances in Gastrointestinal Oncology - WORLD GASTROENTEROLOGY 2026 (Spain)
- Advances in Gastrointestinal Therapeutics - Gastroenterology – 2025 (France)
- Advances in GERD Treatment - WORLD GASTROENTEROLOGY 2026 (Spain)
- Advances in GI Endoscopy & Surgical Precision - Gastrosummit 2025 (France)
- Alcoholic Liver Disease: Emerging Treatments - WORLD GASTROENTEROLOGY 2026 (Spain)
- Barrett’s Esophagus: Current Therapeutics - WORLD GASTROENTEROLOGY 2026 (Spain)
- Celiac Disease and Gluten-Related Disorders - Gastroenterology – 2025 (France)
- Celiac Disease: Latest Treatment Options - WORLD GASTROENTEROLOGY 2026 (Spain)
- Colorectal Cancer: Prevention, Screening, and Treatment - Gastroenterology – 2025 (France)
- Diagnostic Biomarkers and Therapeutic Targets in Digestive Diseases - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Digestive System Cancers - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Disorders of the Small Bowel and Colon - Gastrosummit 2025 (France)
- Disorders of the Small Bowel and Colon - Gastrosummit 2025 (France)
- Emerging Therapies for Crohn's - WORLD GASTROENTEROLOGY 2026 (Spain)
- Endoscopic Innovations and Techniques - Gastroenterology – 2025 (France)
- Endoscopy and Minimally Invasive Gastrointestinal Procedures - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Esophageal and Gastric Disease - Gastrosummit 2025 (France)
- Esophageal Disorders: Current Treatments - WORLD GASTROENTEROLOGY 2026 (Spain)
- Functional GI Disorders: IBS and Beyond - Gastroenterology – 2025 (France)
- Gastroenterology - Gastrosummit 2025 (France)
- Gastrointestinal Cancer - Gastrosummit 2025 (France)
- Gastrointestinal Disorders and Treatment - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gastrointestinal Infections and Antimicrobial Resistance - Gastroenterology – 2025 (France)
- Gastrointestinal Infections and Immunity - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gastrointestinal Oncology and Tumor Biology - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gastrointestinal Oncology: From Screening to Targeted Therapies - Gastroenterology – 2025 (France)
- Gastrointestinal Pharmacotherapy - Gastrosummit 2025 (France)
- Gastrointestinal Stromal Tumors: Novel Therapies - WORLD GASTROENTEROLOGY 2026 (Spain)
- GI Oncology: Colorectal and Pancreatic Cancers - Gastroenterology – 2025 (France)
- Gut Microbiota and Gastrointestinal Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Gut Microbiota and Metabolic Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Hepatic Encephalopathy: Modern Management Strategies - WORLD GASTROENTEROLOGY 2026 (Spain)
- Hepatitis C Therapeutics - WORLD GASTROENTEROLOGY 2026 (Spain)
- Hepatocellular Carcinoma: Latest Approaches - WORLD GASTROENTEROLOGY 2026 (Spain)
- Hepatology - Gastrosummit 2025 (France)
- Hepatology: Liver Disease and Transplantation - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Impact of COVID-19 on Gastroenterology Practice - Gastrosummit 2025 (France)
- Inflammatory Bowel Disease (IBD): Crohn’s and Ulcerative Colitis - Gastroenterology – 2025 (France)
- Inflammatory Bowel Disease (IBD): Insights and Advancements - Gastroenterology – 2025 (France)
- Inflammatory Bowel Disease and Intestinal Inflammation - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Inflammatory Bowel Diseases - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Innovations in IBD Management - WORLD GASTROENTEROLOGY 2026 (Spain)
- Insights into Celiac Disease - Gastrosummit 2025 (France)
- Insights into Celiac Disease - Gastrosummit 2025 (France)
- Insights into Gastrointestinal Pathology - Gastrosummit 2025 (France)
- Liver and Pancreatic Disorders - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Liver Cirrhosis and Complications - Gastroenterology – 2025 (France)
- Liver Cirrhosis: New Therapies - WORLD GASTROENTEROLOGY 2026 (Spain)
- Liver Diseases and Hepatic Disorders - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Liver Diseases and Hepatology - Gastroenterology – 2025 (France)
- Microbiome and Gastrointestinal Health - WORLD GASTROENTEROLOGY 2026 (Spain)
- Microbiome and Gut Health - Gastroenterology – 2025 (France)
- NAFLD and NASH Treatments - WORLD GASTROENTEROLOGY 2026 (Spain)
- New Approaches to Peptic Ulcer Disease - WORLD GASTROENTEROLOGY 2026 (Spain)
- Non-Alcoholic Fatty Liver Disease - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Non-Alcoholic Fatty Liver Disease (NAFLD) and NASH - Gastroenterology – 2025 (France)
- Nutrition and Aging: Geriatric Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Paediatric Gastroenterology - Gastrosummit 2025 (France)
- Pancreatic and Biliary Disease - Gastrosummit 2025 (France)
- Pancreatitis: Modern Therapeutic Strategies - WORLD GASTROENTEROLOGY 2026 (Spain)
- Pediatric and Adolescent Nutrition - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Pediatric Gastroenterology and Nutrition - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Pediatric Gastroenterology: Challenges and Innovations - Gastroenterology – 2025 (France)
- Peptic Ulcer and Acid-related Disorders - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Peptic Ulcer Disease and H. pylori Infection - Gastroenterology – 2025 (France)
- Plant-Based Nutrition and Sustainable Diets - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- Role of Microbiota in Digestive Health - DIGESTIVE AND METABOLIC DISEASES 2026 (France)
- The Microbiota Universe - Gastrosummit 2025 (France)
- Therapeutics for Biliary Diseases - WORLD GASTROENTEROLOGY 2026 (Spain)
- Ulcerative Colitis: Innovative Treatments - WORLD GASTROENTEROLOGY 2026 (Spain)
- Viral Hepatitis: New Treatment Paradigms - WORLD GASTROENTEROLOGY 2026 (Spain)